Search Results - "Cho, Naoki"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Formation of reactive metabolites of benzbromarone in humanized-liver mice by Cho, Naoki, Suemizu, Hiroshi, Kamimura, Hidetaka, Ohe, Tomoyuki, Ito, Fumi, Akita, Hidetaka, Kobayashi, Kaoru

    Published in Drug metabolism and pharmacokinetics (01-12-2022)
    “…Benzbromarone, a uricosuric drug, has the potential to cause serious hepatotoxicity. Several studies have shown the formation of reactive metabolites of…”
    Get full text
    Journal Article
  2. 2

    Identification of novel glutathione adducts of benzbromarone in human liver microsomes by Cho, Naoki, Kobayashi, Kaoru, Yoshida, Mina, Kogure, Noriyuki, Takayama, Hiromitsu, Chiba, Kan

    Published in Drug metabolism and pharmacokinetics (01-02-2017)
    “…Benzbromarone (BBR) is a potent uricosuric drug that can cause serious liver injury. Our recent study suggested that 1′-hydroxy BBR, one of major metabolites…”
    Get full text
    Journal Article
  3. 3

    Safety, Tolerability, and Pharmacokinetics of a Novel Oral Phosphodiesterase 4 Inhibitor, ME3183: First‐in‐Human Phase 1 Study by Kato, Seiji, Cho, Naoki, Koresawa, Tomokazu, Otake, Kazunari, Kano, Akiko

    Published in Clinical pharmacology in drug development (01-04-2024)
    “…A novel, oral phosphodiesterase 4 (PDE4) inhibitor, ME3183, is under development for the treatment of psoriasis, atopic dermatitis, and other inflammatory…”
    Get full text
    Journal Article
  4. 4

    ME3183, a novel phosphodiesterase-4 inhibitor, exhibits potent anti-inflammatory effects and is well tolerated in a non-clinical study by Kubota-Ishida, Natsuki, Kaji, Chizuko, Matsumoto, Shogo, Wakabayashi, Tsubasa, Matsuhira, Takashi, Okura, Iori, Cho, Naoki, Isshiki, Satoshi, Kumura, Ko, Tabata, Yuji

    Published in European journal of pharmacology (05-01-2024)
    “…Phosphodiesterase 4 (PDE4) inhibitors are expected to exhibit efficacy against inflammatory diseases due to their broad pharmacological activity. The launched…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Association of a reactive intermediate derived from 1′,6‐dihydroxy metabolite with benzbromarone‐induced hepatotoxicity by Yoshida, Mina, Cho, Naoki, Akita, Hidetaka, Kobayashi, Kaoru

    “…Treatment with benzbromarone can be associated with liver injury, but the detailed mechanism remains unknown. Our recent studies demonstrated that…”
    Get full text
    Journal Article